The global CNS therapeutic market is expected to
reach USD 128.9 billion by 2025. Rising prevalence of mental illnesses and increasing
awareness regarding psychiatric disorders are driving market growth. In
addition, expanding geriatric population and rising prevalence of
lifestyle-associated CNS disorders are increasing global demand for CNS
therapeutics.
Access
Full Report With TOC @ http://www.radiantinsights.com/research/central-nervous-system-cns-therapeutic-market
Mental health segment accounted for the largest
market share in 2016. It is expected to retain its dominance over the forecast
period owing to developing therapeutic options for mental diseases such as
personality disorders and binge eating disorders. This segment is followed by
degenerative disorders segment. There is growing awareness regarding
neurodegenerative diseases owing to increase in initiatives by government and
nongovernment organizations, such as Alzheimer's and Related Disorders Society
of India. These organizations conduct awareness campaigns and conferences, such
as Asia Pacific Conference of ADI at New Delhi and Kerala State Initiative on
Dementia, which encourage the adoption of treatment for degenerative and mental
disorders.
Cancer segment is expected to emerge as the fastest
growing segment in the Central Nervous System therapeutics market. High demand
for effective treatment and a large number of drugs in later phases of clinical
trials are factors expected to propel the growth of the segment.
Request
A Sample Copy Of This Report at: http://www.radiantinsights.com/research/central-nervous-system-cns-therapeutic-market/request-sample
Further
key findings from the report suggest:
- Global mental health therapeutics revenue accounted for 48% share in 2016 and is expected to grow at a significant rate from 2016 to 2025
- Global demand for the treatment of Parkinson's and Alzheimer's diseases is anticipated to witness extensive growth over the next 9 years
- The industry in Asia Pacific is expected to report fastest growth over the forecast period owing to various developments across major economies of the region, especially in the mental health sector.
- Key players including Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.; Biogen, Inc.; Johnson & Johnson Services, Inc.; Eli Lilly and Company; and Novartis AG led the global CNS disease treatment market by capturing a majority share
About
Radiant Insights,Inc
Radiant Insights is a platform for companies looking
to meet their market research and business intelligence requirements. We assist
and facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
Media
Contact:
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: sales@radiantinsights.com
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: sales@radiantinsights.com
No comments:
Post a Comment